Development

Articles

Novo Nordisk will expand its existing research collaboration in novel delivery technologies with MIT and Brigham and Women’s Hospital.

Novo Nordisk Expands Research Collaboration in Novel Delivery Technologies for Biologic Medicines

The agreement expands Pfizer’s access to LNP formulation technology for mRNA vaccines and therapeutics.

Pfizer and Acuitas Therapeutics Collaborate on Lipid Nanoparticle Delivery System 

Fujifilm’s center adds local support in Suzhou, China for cell culture media optimization.

Fujifilm Irvine Scientific Builds Bioprocessing Innovation and Collaboration Center in China

Tezepelumab, being developed by AstraZeneca in collaboration with Amgen, reduced asthma exacerbations in Phase II and III clinical trials. 

FDA Grants Priority Review for AstraZeneca Asthma Biologic

Eli Lilly and Company has partnered with leading diabetes tech firms to offer app compatibility with insulin smart pens to streamline diabetes management with automated data collection.

Lilly Forms Pact with Diabetes Tech Companies to Integrate Connected Insulin Pen Solutions

Editor of Pharmaceutical Technology Europe

Vaccine development is inherently challenging; however, in light of the COVID-19 pandemic, innovations have been prioritized, leading to accelerated development processes.

Overcoming Vaccine Development Challenges

The inhaled route of administration for biologics is experiencing renewed interest, particularly in light of the COVID-19 pandemic.

Taking a Breath: Advances in Inhaled Biologics

Feliza Mirasol is the science editor for 

Current and newer biologic modalities pose increasingly complex challenges to the detection and characterization of protein aggregates.

Risky Business: Assessing Protein Aggregation Grows Increasingly Challenging

Agnes Shanley is senior editor of Pharmaceutical Technology.

Manufacturers and the US government are investing heavily in traditional and non-traditional forms and materials to ensure supplies of containers and delivery devices for COVID-19 treatments and vaccines. 


COVID-19: Shoring Up the Drug Delivery Infrastructure

Cynthia A. Challener, PhD, is a contributing editor to BioPharm International.

RNA is easier to manipulate than DNA but challenging to deliver to the right cells.

Formulation and Drug Delivery, Biologic Drugs